ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,632.33
1.05%
Dow Jones
41,488.19
1.65%
Gold vs US Dollar
2,986.65
0.00%
Brent Oil
70.285
0.00%
Bitcoin
84,210.21
0.30%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Intelligent Bio Solutions Inc (INBS)

  7. Intelligent Bio Solutions Inc (INBS) News

Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INBS
DateTimeSourceHeadlineSymbolCompany
14/03/202520:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
12/03/202512:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
11/03/202521:26Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INBSIntelligent Bio Solutions Inc
11/03/202512:30GlobeNewswire Inc.Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26thNASDAQ:INBSIntelligent Bio Solutions Inc
21/02/202522:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
21/02/202521:05GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common StockNASDAQ:INBSIntelligent Bio Solutions Inc
21/02/202511:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INBSIntelligent Bio Solutions Inc
20/02/202521:45Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INBSIntelligent Bio Solutions Inc
20/02/202513:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common StockNASDAQ:INBSIntelligent Bio Solutions Inc
19/02/202521:42GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common StockNASDAQ:INBSIntelligent Bio Solutions Inc
19/02/202521:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INBSIntelligent Bio Solutions Inc
13/02/202522:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
13/02/202522:15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
13/02/202513:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBSIntelligent Bio Solutions Inc
13/02/202513:30GlobeNewswire Inc.Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational AchievementsNASDAQ:INBSIntelligent Bio Solutions Inc
10/02/202522:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
07/02/202522:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
07/02/202513:30GlobeNewswire Inc.Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. LaunchNASDAQ:INBSIntelligent Bio Solutions Inc
06/02/202522:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
06/02/202514:00GlobeNewswire Inc.Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin SalesNASDAQ:INBSIntelligent Bio Solutions Inc
31/01/202522:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
31/01/202514:00GlobeNewswire Inc.Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System UpgradeNASDAQ:INBSIntelligent Bio Solutions Inc
29/01/202522:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
29/01/202514:00GlobeNewswire Inc.Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug TestingNASDAQ:INBSIntelligent Bio Solutions Inc
28/01/202522:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
28/01/202514:00GlobeNewswire Inc.Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern RegionsNASDAQ:INBSIntelligent Bio Solutions Inc
14/01/202513:30GlobeNewswire Inc.Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK SitesNASDAQ:INBSIntelligent Bio Solutions Inc
06/01/202522:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
18/12/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
18/12/202413:30GlobeNewswire Inc.Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening TechnologyNASDAQ:INBSIntelligent Bio Solutions Inc
 Showing the most relevant articles for your search:NASDAQ:INBS

Your Recent History

EU
ALTA
Altarea
LSE
0QGS
Morefield Group Nv
LSE
REVB
Revolution Beauty
TG
AEX
Chubb
LSE
0NIQ
Sartorius
BOV
PINE3
PINE ON
LSE
SNX
Synectics
LSE
CRM3
Ls 3x Crm
EU
XS2783604742
TenneT Holding BV Bond 4...
AQSE
CEG.GB
Challenger Energy
LSE
13PH
Citigroup
LSE
APPS
Appscatter
LSE
0Q3A
Opimus Group Nyrt
EU
INEA
Fonciere Inea
BOV
PETR3
PETROBRAS ON
BOV
ENGI3
ENERGISA ON
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads